The UW/FHCRC CFAR Administration Core is responsible for strategic planning and operational management of the CFAR. The CFAR Administration Core is co-located with the Dept of Global Health Administration Team and with the Administration Core of the UW Center for AIDS and STD, a permanent Center based in the Infectious Diseases Division, also directed by Dr. Holmes, which supports the CFAR efforts to coordinate its HIV/AIDS research, other research training, and community outreach activities with similar programs involving STD.
The Aims of the Administration Core are: 1) Support collaborative, interdisciplinary, translational HIV/AIDS research and research training to pursue the CFAR Strategic Research Priorities and Specific Aims. This includes coordinating HIV/AIDS research and research training programs domestically and globally, to expand basic discovery research, prevent new infections, and improve HIV disease outcomes. To support this Aim, the Core promotes growth of funding, facilities and other resources and infrastructure needed for HIV/AIDS research and research training;provides educational and research training opportunities, and scientific communication to investigators, trainees, and the community;and maintains active inter-CFAR participation;and 2) Efficient, effective, timely, collegial operational management of the CFAR. including strategic planning leading to exciting, aspirational, futuristic plans for going forward in the most promising research areas;implementing CFAR activities according to CFAR principles, policies, and procedures;managing pre- and post-award and personnel administration;supporting Core and Scientific Working Group functions;and effectively advertising and promoting CFAR services and activities. The Core supports many HIV/AIDS-related courses, seminars, symposia, and workshops to promote scientific communication and facilitate collaboration. The Core works closely with: UW Advancement on raising private funding for HIV/AIDS research;the Dean of Medicine, and the UW Provost and CEOs of affiliated institutions, obtaining substantial commitments in matching funds and required space for the CFAR and CFAR members;the Consortium Research Leadership in organizing responses to new research opportunities;with the UW Office of Global Affairs, Global Support Project, in establishing and sustaining international partnerships;with other UW Research Centers and Institutes;with local, state, and federal agencies;and with community-based organizations for collaborative leadership and management.
The Administration Core manages the CFAR Cores and SWGs that support HIV researchers at our 4 consortium institutions, coordinates outreach to CFAR scientists and staff, to related local, national, and global research programs, centers, institutes, health centers, and consortium partner leadership;and to the community. It is through this support that the Core has an impact on medicine and public health, on preventing new HIV infections, improving health outcomes, and basic discovery science .
|Stekler, Joanne D; McKernan, Jennifer; Milne, Ross et al. (2015) Lack of resistance to integrase inhibitors among antiretroviral-naive subjects with primary HIV-1 infection, 2007-2013. Antivir Ther 20:77-80|
|Mohanraj, Rani; Jeyaseelan, Visalakshi; Kumar, Shuba et al. (2015) Cultural adaptation of the Brief COPE for persons living with HIV/AIDS in southern India. AIDS Behav 19:341-51|
|Slyker, Jennifer A; Casper, Corey; Tapia, Kenneth et al. (2014) Accelerated suppression of primary Epstein-Barr virus infection in HIV-infected infants initiating lopinavir/ritonavir-based versus nevirapine-based combination antiretroviral therapy. Clin Infect Dis 58:1333-7|
|Mackelprang, Romel D; Bigham, Abigail W; Celum, Connie et al. (2014) Toll-like receptor polymorphism associations with HIV-1 outcomes among sub-Saharan Africans. J Infect Dis 209:1623-7|
|Gantt, Soren; Cattamanchi, Ashok; Krantz, Elizabeth et al. (2014) Reduced human herpesvirus-8 oropharyngeal shedding associated with protease inhibitor-based antiretroviral therapy. J Clin Virol 60:127-32|
|Puttkammer, Nancy H; Zeliadt, Steven B; Balan, Jean Gabriel et al. (2014) Before and after the earthquake: a case study of attrition from the HIV antiretroviral therapy program in Haiti. Glob Health Action 7:24572|
|Gerdts, Sarah E; Wagenaar, Bradley H; Micek, Mark A et al. (2014) Linkage to HIV care and antiretroviral therapy by HIV testing service type in Central Mozambique: a retrospective cohort study. J Acquir Immune Defic Syndr 66:e37-44|
|Liu, Yi; Rao, Ushnal; McClure, Jan et al. (2014) Impact of mutations in highly conserved amino acids of the HIV-1 Gag-p24 and Env-gp120 proteins on viral replication in different genetic backgrounds. PLoS One 9:e94240|
|Chung, Michael H; Beck, Ingrid A; Dross, Sandra et al. (2014) Oligonucleotide ligation assay detects HIV drug resistance associated with virologic failure among antiretroviral-naive adults in Kenya. J Acquir Immune Defic Syndr 67:246-53|
|Pantalone, David W; Huh, David; Nelson, Kimberly M et al. (2014) Prospective predictors of unprotected anal intercourse among HIV-seropositive men who have sex with men initiating antiretroviral therapy. AIDS Behav 18:78-87|
Showing the most recent 10 out of 552 publications